Advertisement
Screener

9 Meters Biopharma, Inc. Share-based Payment Arrangement, Expense

9 Meters Biopharma, Inc. Share-based Payment Arrangement, Expense

9 Meters Biopharma, Inc. reported Share-based Payment Arrangement, Expense of $737.00 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-15.

Discontinued › Expense Statement › Operating Expenses

us-gaap:AllocatedShareBasedCompensationExpense · last filed 2023-05-15

  • 9 Meters Biopharma, Inc. share-based payment arrangement, expense for the quarter ending 2023-03-31 was $737.00K, a 6.81% increase year-over-year.
  • 9 Meters Biopharma, Inc. share-based payment arrangement, expense for the quarter ending 2022-12-31 was $744.00K, a 40.64% increase year-over-year.
  • 9 Meters Biopharma, Inc. share-based payment arrangement, expense for the quarter ending 2022-09-30 was $730.00K, a 39.05% increase year-over-year.
  • 9 Meters Biopharma, Inc. share-based payment arrangement, expense for the quarter ending 2022-06-30 was $1.77M, a 89.33% increase year-over-year.
  • 9 Meters Biopharma, Inc. share-based payment arrangement, expense for fiscal 2022 was $3.94M, a 63.20% increase from fiscal 2021.
  • 9 Meters Biopharma, Inc. share-based payment arrangement, expense for fiscal 2021 was $2.41M, a 48.91% decline from fiscal 2020.
  • 9 Meters Biopharma, Inc. share-based payment arrangement, expense for fiscal 2020 was $4.72M, a 64.51% increase from fiscal 2019.
  • 9 Meters Biopharma, Inc. share-based payment arrangement, expense for fiscal 2019 was $2.87M, a 24.55% decline from fiscal 2018.
Period endShare-based Payment Arrangement, Expense 3 monthShare-based Payment Arrangement, Expense 6 monthShare-based Payment Arrangement, Expense 6 month as first filedShare-based Payment Arrangement, Expense 9 monthShare-based Payment Arrangement, Expense 9 month as first filedShare-based Payment Arrangement, Expense 12 month
2023-03-31$737.00K
10-Q · filed 2023-05-15
$1.48M
derived: sum of 2 quarters · filed 2023-05-15
$2.21M
derived: sum of 3 quarters · filed 2023-05-15
$3.98M
derived: sum of 4 quarters · filed 2023-05-15
2022-12-31$744.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28
$1.47M
derived: sum of 2 quarters · filed 2023-03-28
$3.25M
derived: sum of 3 quarters · filed 2023-03-28
$3.94M
10-K · filed 2023-03-28
2022-09-30$730.00K
10-Q · filed 2022-11-08
$2.50M
derived: sum of 2 quarters · filed 2022-11-08
$3.19M
10-Q · filed 2022-11-08
$3.72M
derived: sum of 4 quarters · filed 2023-05-15
2022-06-30$1.77M
10-Q · filed 2022-08-15
$2.46M
10-Q · filed 2022-08-15
$2.99M
derived: sum of 3 quarters · filed 2023-05-15
$3.52M
derived: sum of 4 quarters · filed 2023-05-15
2022-03-31$690.00K
10-Q · filed 2023-05-15
$1.22M
derived: sum of 2 quarters · filed 2023-05-15
$1.74M
derived: sum of 3 quarters · filed 2023-05-15
$2.68M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$529.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28
$1.05M
derived: sum of 2 quarters · filed 2023-03-28
$1.99M
derived: sum of 3 quarters · filed 2023-03-28
$2.41M
10-K · filed 2023-03-28
2021-09-30$525.00K
10-Q · filed 2022-11-08
$1.46M
derived: sum of 2 quarters · filed 2022-11-08
$1.88M
10-Q · filed 2022-11-08
$2.11M
derived: sum of 4 quarters · filed 2022-11-08
2021-06-30$937.00K
10-Q · filed 2022-08-15
$1.36M
10-Q · filed 2022-08-15
$1.58M
derived: sum of 3 quarters · filed 2022-08-15
$1.78M
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31$422.00K
10-Q · filed 2022-05-16
$646.00K
derived: sum of 2 quarters · filed 2022-05-16
$848.00K
derived: sum of 3 quarters · filed 2022-05-16
$4.87M
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31$224.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23
$426.00K
derived: sum of 2 quarters · filed 2022-03-23
$4.45M
derived: sum of 3 quarters · filed 2022-03-23
$4.72M
10-K · filed 2022-03-23
2020-09-30$202.00K
10-Q · filed 2021-11-15
$4.22M
derived: sum of 2 quarters · filed 2021-11-15
$4.50M
10-Q · filed 2021-11-15
$5.09M
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30$4.02M
10-Q · filed 2021-08-12
$4.30M
10-Q · filed 2021-08-12
$4.89M
derived: sum of 3 quarters · filed 2021-08-12
$5.79M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31$276.00K
10-Q · filed 2021-05-13
$869.00K
derived: sum of 2 quarters · filed 2021-05-13
$1.77M
derived: sum of 3 quarters · filed 2021-05-13
$2.62M
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31$593.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22
$1.49M
derived: sum of 2 quarters · filed 2021-03-22
$2.35M
derived: sum of 3 quarters · filed 2021-03-22
$2.87M
10-K · filed 2021-03-22
2019-09-30$900.00K
10-Q · filed 2020-11-09
$1.75M
derived: sum of 2 quarters · filed 2020-11-09
$2.28M
10-Q · filed 2020-11-09
$2.22M
derived: sum of 4 quarters · filed 2020-11-09
2019-06-30$852.00K
10-Q · filed 2020-08-13
$1.38M
10-Q · filed 2020-08-13
$1.32M
derived: sum of 3 quarters · filed 2020-08-13
-$1.81M
derived: sum of 4 quarters · filed 2020-08-13
2019-03-31$526.00K
10-Q · filed 2020-05-15
$472.00K
derived: sum of 2 quarters · filed 2020-05-15
-$2.66M
derived: sum of 3 quarters · filed 2020-05-15
-$2.84M
derived: sum of 4 quarters · filed 2020-05-15
2018-12-31-$54.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-20
-$3.19M
derived: sum of 2 quarters · filed 2020-03-20
-$3.37M
derived: sum of 3 quarters · filed 2020-03-20
$3.81M
10-K · filed 2020-03-20
2018-09-30-$3.13M
10-Q · filed 2019-11-07
-$3.31M
derived: sum of 2 quarters · filed 2019-11-07
$3.86M
10-Q · filed 2019-11-07
$5.05M
10-Q · filed 2018-11-13
$5.13M
derived: sum of 4 quarters · filed 2019-11-07
2018-06-30-$184.00K
10-Q · filed 2019-08-08
$6.99M
10-Q · filed 2019-08-08
$8.19M
10-Q · filed 2018-08-14
$8.26M
derived: sum of 3 quarters · filed 2019-08-08
$9.54M
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31$7.17M
10-Q · filed 2019-05-10
$8.44M
derived: sum of 2 quarters · filed 2019-05-10
$9.72M
derived: sum of 3 quarters · filed 2019-05-10
$10.81M
derived: sum of 4 quarters · filed 2019-05-10
2017-12-31$1.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18
$2.55M
derived: sum of 2 quarters · filed 2019-03-18
$3.63M
derived: sum of 3 quarters · filed 2019-03-18
$6.02M
10-K · filed 2019-03-18
2017-09-30$1.28M
10-Q · filed 2018-11-13
$2.36M
derived: sum of 2 quarters · filed 2018-11-13
$4.75M
10-Q · filed 2018-11-13
2017-06-30$1.09M
10-Q · filed 2018-08-14
$3.47M
10-Q · filed 2018-08-14